Involvement of endogenous kinins in the pathogenesis of peptidoglycan- induced arthritis in the lewis rat

Arthritis and Rheumatism

Volumn 40, Issue 7, 1997, Pages 1327-1333

  Blais Jr , Charles ^a   Couture, Réjean ^a   Drapeau, Guy ^b   Colman, Robert W ^c   Adam, Albert ^a  

^a UNIVERSITÉ DE MONTRÉAL   (Canada)

^b LAVAL UNIVERSITY   (Canada)

^c TEMPLE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACUTE PHASE PROTEIN; BRADYKININ; BRADYKININ B1 RECEPTOR ANTAGONIST; BRADYKININ B2 RECEPTOR ANTAGONIST; BRADYKININ[1-8]; BRADYKININ[8 LEUCINE 9 DEARGININE]; ICATIBANT; KININ; KININOGEN; PEPTIDOGLYCAN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTHRITIS; ARTICLE; CHEMOLUMINESCENCE; CONTROLLED STUDY; ENZYME IMMUNOASSAY; FEMALE; INFLAMMATION; NONHUMAN; OSMOTIC MINIPUMP; PATHOGENESIS; PAW EDEMA; PRIORITY JOURNAL; RAT;

EID: 0030930021     PISSN: 00043591     EISSN: None     Source Type: Journal    
DOI: 10.1002/1529-0131(199707)40:7<1327::AID-ART18>3.0.CO;2-B     Document Type: Article

References (20)

1. Proud D, Kaplan AP: Kinin formation: mechanisms and role in inflammatory disorders. Annu Rev Immunol 6:49-83, 1988
2. Baumann H, Gauldie J: The acute phase response. Immunol Today 15:74-80, 1994
3. Hall JM: Bradykinin receptors: pharmacological properties and biological roles. Pharmacol Ther 56:131-190, 1992
4. 1 receptors: a review. Immunopharmacology 30:1-26, 1995
5. 9]BK in carrageenan-induced edema. Peptides 17:1009-1015, 1996
6. 1 receptors for kinins. J Pharmacol Exp Ther 266:192-199, 1993
7. Décarie A, Drapeau G, Closset J, Couture R, Adam A: Development of digoxigenin-labeled peptide: application to chemiluminoenzyme immunoassay of bradykinin in inflamed tissues. Peptides 15:511-518, 1994
8. 9-bradykinin using a chemiluminescence enzyme immunoassay: application to its kinetic profile during plasma activation. J Immunol Methods 180:247-257, 1995
9. 2-kininogen in liver. J Pharmacol Exp Ther 278:934-940, 1996
10. Magilavy DB: Animal models of chronic inflammatory arthritis. Clin Orthop 259:38-45, 1990
11. Schwab JH: Phlogistic properties of peptidoglycan-polysaccharide polymers from cell walls of pathogenic and normal-flora bacteria which colonize humans. Infect Immun 61:4535-4539, 1993
12. DeLa Cadena RA, Sartor RB, Adam A, Raymond P, Legris F, Colman RW: Role of kallikrein-kinin system in the pathogenesis of bacterial cell wall-induced inflammation and enterocolitis. Trans Assoc Am Physicians 55:229-237, 1992
13. DeLa Cadena RA, Laskin KJ, Pixley RA, Sartor RB, Schwab JH, Back N, Bedi GS, Fisher RS, Colman RW: Role of kallikrein-kinin system in pathogenesis of bacterial cell wall-induced inflammation. Am J Physiol 260:G213-G219, 1991
14. DeLa Cadena RA, Stadnicki A, Uknis AB, Sartor RB, Kettner CA, Adam A, Colman RW: Inhibition of plasma kallikrein prevents peptidoglycan-induced arthritis in the Lewis rat. FASEB J 9:446-452, 1995
15. 2 kinin receptors in the modulation of T-kininogen during the acute phase response of inflammation. Peptides 17:1163-1170, 1996
16. 2-type receptors. Peptides 17:1171-1176, 1996
17. 9]BK: influence of enalaprilat. Am J Physiol 270: H1340-H1347, 1996
18. Melmon KL, Webster ME, Goldfinger SE, Seegmiller JE: The presence of a kinin in inflammatory synovial effusion from arthritides of varying etiologies. Arthritis Rheum 10:13-20, 1967
19. Jasani MK, Katori M, Lewis GP: Intracellular enzymes and kinin enzymes in synovial fluid in joint diseases: origin and relation to disease category. Ann Rheum Dis 28:497-512, 1969
20. Eisen V: Plasma kinins in synovial exudates. Br J Exp Pathol 51:322-327, 1970